Integra LifeSciences (NSDQ:IART) eked out some Wall Street-beating numbers for the 4th quarter and raised its outlook for 2016, prompting investors to send its share price up today. Plainsboro, N.J.-based Integra posted profits of $15.0 million, or 39¢ per share, on sales of $241.2 million for the 3 months ended Dec. 31, 2o15, marking a […]
Integra LifeSciences
FDA clears Integra’s Omnigraft for treating diabetic foot ulcers
Integra LifeSciences (NSDQ:IART) said today it won expanded FDA approval for its Omnigraft dermal regeneration matrix, now indicated to treat diabetic foot ulcers. The device, made of silicone, cow collagen and shark cartilage, is placed over the ulcer to provide a new environment for the skin and tissue to regenerate and heal the wound, according […]
Integra LifeSciences boosts outlook
Integra LifeSciences (NSDQ:IART) yesterday raised its long-term forecast out to 2018, saying it expects to post higher numbers across the board. The new outlook calls for adjusted earnings-per-share growth of 12% or more, up from 10% previously, on organic sales growth of 6% to 8%, up from prior guidance of 5% to 7%. Gross margins […]
Integra closes on Tornier ankles and toes assets
Integra LifeSciences (NSDQ:IART) said it closed its acquisition of the U.S. rights to Tornier‘s (NSDQ:TRNX) Salto Talaris and Salto Talaris XT ankle replacements and Futura silastic toe replacements. Integra said it expects the acquisition will be immaterial to its expected adjusted earnings per share for the 1st year, and said it plans to provide info on […]
Integra Lifesciences sues HyperBranch over Confluent Surgical patents
Integra LifeSciences (NSDQ:IART) yesterday hit rival HyperBranch Medical Technology with a lawsuit alleging infringement of 6 patents related to the DuraSeal neurosurgical sealant it acquired along with Confluent Surgical last year. Covidien dealt its Confluent Surgical line to Integra in January 2014 for $235 million in up-front cash and another $30 million in milestones. Yesterday Integra said Durham, […]
Integra LifeSciences acquires Tornier assets ahead of Wright Medical merger
Integra LifeSciences (NSDQ:IART) agreed to acquire some of Tornier’s (NSDQ:TRNX) ankle and toe assets in the U.S., as the Dutch orthopedics company looks to satisfy anti-trust regulators about its pending, $3.3 billion merger with Wright Medical (NSDQ:WMGI). The deal calls for Integra to acquire the U.S. rights to Tornier’s Salto Talaris and Salto XT ankle replacement devices and […]
Integra Lifesciences closes TEI acquisition
Integra LifeSciences (NSDQ:IART) said today it closed its acquisition of all outstanding shares of TEI Biosciences and TEI Medical. The purchase allows Integra to broaden its portfolio of reconstructive and regenerative wound care products, the Plainsboro, N.J.-based company said. “We are enthusiastic about the strategic fit of these 2 organizations, and the positive impact TEI has […]
Integra LifeSciences prices $201m follow-on
Integra LifeSciences (NSDQ:IART) yesterday priced a 3.3 million-share follow-on stock offering at $61 per share, for expected gross proceeds of $201.3 million. The offering includes a 30-day over-allotment option to purchase an additional 495,000 shares worth $30.2 million, Plainsboro, N.J.-based Integra said. The proceeds will be used to pay down debt, the company said. J.P. Morgan, […]
Integra LifeSciences announces $200m follow-on offering
Integra LifeSciences (NSDQ:IART) said yesterday it is planning a $200 million follow-on stock offering. The offering includes a 30-day over-allotment option to purchase an additional $30 million worth of common shares, Integra LifeSciences said. The Plainsboro, N.J.-based company said the funds are slated to reduce outstanding borrowings with Integra’s senior credit facility. J.P. Morgan, Wells […]
Integra LifeSciences logs Q2 sales, earnings beat; SeaSpine spinout misses with prelims
Integra LifeSciences (NSDQ:IART) beat expectations for its 2nd-quarter sales and earnings, but the medical device company still lowered its outlook for the rest of the year. SeaSpine Holdings (NSDQ:SPNE), Integra’s spine business spinout, didn’t fare as well with its Q2 preliminaries, missing expectations with its top-line prediction. Integra posted profits of $5.0 million, or 15¢ per share, on sales of […]
Integra LifeSciences closes $312m TEI buyout
Integra LifeSciences (NSDQ:IART) said today that it closed its $312 million acquisition of TEI Biosciences and sister company TEI Medical, expanding its footprint in reconstructive surgery and regenerative wound care. The deal brings TEI’s PriMatrix dermal repair scaffold and a 125-member sales force under the Integra umbrella, that Plainsboro, N.J.-based company said. TEI is based in Waltham, Mass. […]